IPHA
Price
$1.82
Change
-$0.03 (-1.62%)
Updated
Jul 2 closing price
Capitalization
165.36M
74 days until earnings call
SLNO
Price
$86.65
Change
+$0.44 (+0.51%)
Updated
Jul 3 closing price
Capitalization
4.37B
32 days until earnings call
Interact to see
Advertisement

IPHA vs SLNO

Header iconIPHA vs SLNO Comparison
Open Charts IPHA vs SLNOBanner chart's image
Innate Pharma SA
Price$1.82
Change-$0.03 (-1.62%)
Volume$5.45K
Capitalization165.36M
Soleno Therapeutics
Price$86.65
Change+$0.44 (+0.51%)
Volume$330.11K
Capitalization4.37B
IPHA vs SLNO Comparison Chart in %
Loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. SLNO commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a Hold and SLNO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (IPHA: $1.82 vs. SLNO: $86.65)
Brand notoriety: IPHA and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 25% vs. SLNO: 39%
Market capitalization -- IPHA: $165.36M vs. SLNO: $4.37B
IPHA [@Biotechnology] is valued at $165.36M. SLNO’s [@Biotechnology] market capitalization is $4.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • IPHA’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNO is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 5 TA indicator(s) are bullish while SLNO’s TA Score has 4 bullish TA indicator(s).

  • IPHA’s TA Score: 5 bullish, 5 bearish.
  • SLNO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IPHA and SLNO are a good buy in the short-term.

Price Growth

IPHA (@Biotechnology) experienced а +2.53% price change this week, while SLNO (@Biotechnology) price change was +3.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

IPHA is expected to report earnings on Sep 17, 2025.

SLNO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($4.37B) has a higher market cap than IPHA($165M). SLNO YTD gains are higher at: 92.770 vs. IPHA (-1.087).
IPHASLNOIPHA / SLNO
Capitalization165M4.37B4%
EBITDAN/A-194.63M-
Gain YTD-1.08792.770-1%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A290M-
Total DebtN/A52.8M-
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPHASLNO
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend about 1 month ago
73%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YECO0.09N/A
N/A
Yulong Eco-Materials Limited
JUMSY32.05N/A
N/A
Jumbo SA
MONRF62.17N/A
N/A
Moncler S.P.A.
ADLRF13.80N/A
N/A
ALARIS EQUITY PARTNERS INCOME TR
SMDRF0.53-0.02
-3.37%
Sierra Madre Gold and Silver Ltd.

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
N/A
MDGL - IPHA
43%
Loosely correlated
-0.43%
SLNO - IPHA
34%
Loosely correlated
+0.51%
VALN - IPHA
30%
Poorly correlated
N/A
QSI - IPHA
28%
Poorly correlated
N/A
VKTX - IPHA
27%
Poorly correlated
+1.70%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+0.51%
BRNS - SLNO
56%
Loosely correlated
-2.63%
KANT - SLNO
45%
Loosely correlated
N/A
SYRE - SLNO
43%
Loosely correlated
+1.68%
NKTX - SLNO
42%
Loosely correlated
+0.57%
SVRA - SLNO
40%
Loosely correlated
+4.29%
More